NCT03510455 2021-04-08BGJ398 for the Treatment of Tumor-Induced OsteomalaciaNational Institutes of Health Clinical Center (CC)Phase 2 Terminated4 enrolled 28 charts
NCT00622479 2014-12-18Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.BayerPhase 1 Terminated12 enrolled